Related Experiment Video
Updated: Sep 10, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Degree of Adherence to Recommendations From the Spanish Consensus on the Reduction of Oral Corticosteroid Use in
Javier Domínguez-Ortega1,2, Xavier Muñoz Gall2,3, Julio Delgado Romero4
1Department of Allergy, Hospital Universitario La Paz, Institute for Health Research (IDIPAZ), Madrid, Spain.
Introduction:
The Spanish consensus on the reduction of oral corticosteroid (OCS) use in asthma management was recently published to address the issue of OCS overuse in this area. This study evaluates the degree of awareness and implementation of this consensus by healthcare professionals.
Methods:
A longitudinal study was conducted with a survey completed by pulmonologists and allergists in 2 rounds conducted 6 months apart. Key metrics included OCS prescribing rates, adherence to recommendations, and other clinician-reported practices.
Results:
Both rounds were completed by 112 and 115 participants, respectively, with equal representation from allergists and pulmonologists. Most (91.1%) were familiar with the consensus, and 58.0% rated their knowledge as high. Fifty-three percent reported increased knowledge after 6 months. Regarding OCS dosing, 70.5% in the first round and 66.1% in the second round considered 5 mg/day of prednisone to be low-dose therapy. A majority routinely calculated annual OCS doses, with a notable rise in the use of digital tools for dose calculations. Most clinicians favored 5-7 days for short OCS courses and supported the use of biologics for patients with uncontrolled severe asthma on maintenance OCS.
Conclusions:
These findings suggest a notable reduction in OCS use and improved adherence to asthma management guidelines following the publication of the Spanish consensus. Repeated educational interventions appear effective in modifying prescribing behaviors and optimizing asthma care.
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:

